The TRIM-NHL protein NHL-2 is a co-factor in the nuclear and somatic RNAi pathways in C. elegans

  1. Gregory M Davis
  2. Shikui Tu
  3. Joshua W T Anderson
  4. Rhys N Colson
  5. Menachem J Gunzburg
  6. Michelle A Francisco
  7. Debashish Ray
  8. Sean P Shrubsole
  9. Julia A Sobotka
  10. Uri Seroussi
  11. Robert X Lao
  12. Tuhin Maity
  13. Monica Z Wu
  14. Katherine McJunkin
  15. Quaid D Morris
  16. Timothy R Hughes
  17. Jacqueline A Wilce  Is a corresponding author
  18. Julie M Claycomb  Is a corresponding author
  19. Zhiping Weng  Is a corresponding author
  20. Peter R Boag  Is a corresponding author
  1. Federation University, Australia
  2. University of Massachusetts Medical School, United States
  3. Monash University, Australia
  4. University of Toronto, Canada
  5. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, United States

Abstract

Proper regulation of germline gene expression is essential for fertility and maintaining species integrity. In the C. elegans germline, a diverse repertoire of regulatory pathways promote the expression of endogenous germline genes and limit the expression of deleterious transcripts to maintain genome homeostasis. Here we show that the conserved TRIM-NHL protein, NHL-2, plays an essential role in the C. elegans germline, modulating germline chromatin and meiotic chromosome organization. We uncover a role for NHL-2 as a co-factor in both positively (CSR-1) and negatively (HRDE-1) acting germline 22G-small RNA pathways and the somatic nuclear RNAi pathway. Furthermore, we demonstrate that NHL-2 is a bona fide RNA binding protein and, along with RNA-seq data point to a small RNA independent role for NHL-2 in regulating transcripts at the level of RNA stability. Collectively, our data implicate NHL-2 as an essential hub of gene regulatory activity in both the germline and soma.

Data availability

All small RNA and mRNA Illumina sequencing data have been submitted to the NCBI's Sequence Read Archive (SRA), and are included under project accession number SRP115391.

The following data sets were generated

Article and author information

Author details

  1. Gregory M Davis

    School of Applied and Biomedical Sciences, Federation University, Gippsland, Australia
    Competing interests
    The authors declare that no competing interests exist.
  2. Shikui Tu

    Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Joshua W T Anderson

    Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Monash University, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  4. Rhys N Colson

    Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Monash University, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  5. Menachem J Gunzburg

    Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Monash University, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  6. Michelle A Francisco

    Department of Molecular Genetics, University of Toronto, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
  7. Debashish Ray

    Department of Molecular Genetics, University of Toronto, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
  8. Sean P Shrubsole

    Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Monash University, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  9. Julia A Sobotka

    Department of Molecular Genetics, University of Toronto, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
  10. Uri Seroussi

    Department of Molecular Genetics, University of Toronto, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
  11. Robert X Lao

    Department of Molecular Genetics, University of Toronto, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
  12. Tuhin Maity

    Department of Molecular Genetics, University of Toronto, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
  13. Monica Z Wu

    Department of Molecular Genetics, University of Toronto, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
  14. Katherine McJunkin

    Laboratory of Cellular and Developmental Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Quaid D Morris

    Department of Molecular Genetics, University of Toronto, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
  16. Timothy R Hughes

    Department of Molecular Genetics, University of Toronto, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
  17. Jacqueline A Wilce

    Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Monash University, Melbourne, Australia
    For correspondence
    jackie.wilce@monash.edu
    Competing interests
    The authors declare that no competing interests exist.
  18. Julie M Claycomb

    Department of Molecular Genetics, University of Toronto, Toronto, Canada
    For correspondence
    julie.claycomb@utoronto.ca
    Competing interests
    The authors declare that no competing interests exist.
  19. Zhiping Weng

    Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, United States
    For correspondence
    zhiping.weng@umassmed.edu
    Competing interests
    The authors declare that no competing interests exist.
  20. Peter R Boag

    Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia
    For correspondence
    peter.boag@monash.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0889-0859

Funding

National Health and Medical Research Council (606575)

  • Peter R Boag

Canada Research Chairs (MOP-274660)

  • Julie M Claycomb

Canadian Institutes of Health Research (MOP-125894)

  • Quaid D Morris
  • Timothy R Hughes

Connaught Fund

  • Julie M Claycomb

National Institutes of Health (HD078253)

  • Zhiping Weng

Canada Research Chairs (CAP- 783 262134)

  • Julie M Claycomb

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 2,341
    views
  • 303
    downloads
  • 17
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Gregory M Davis
  2. Shikui Tu
  3. Joshua W T Anderson
  4. Rhys N Colson
  5. Menachem J Gunzburg
  6. Michelle A Francisco
  7. Debashish Ray
  8. Sean P Shrubsole
  9. Julia A Sobotka
  10. Uri Seroussi
  11. Robert X Lao
  12. Tuhin Maity
  13. Monica Z Wu
  14. Katherine McJunkin
  15. Quaid D Morris
  16. Timothy R Hughes
  17. Jacqueline A Wilce
  18. Julie M Claycomb
  19. Zhiping Weng
  20. Peter R Boag
(2018)
The TRIM-NHL protein NHL-2 is a co-factor in the nuclear and somatic RNAi pathways in C. elegans
eLife 7:e35478.
https://doi.org/10.7554/eLife.35478

Share this article

https://doi.org/10.7554/eLife.35478

Further reading

    1. Chromosomes and Gene Expression
    Carmina Lichauco, Eric J Foss ... Antonio Bedalov
    Research Article

    The association between late replication timing and low transcription rates in eukaryotic heterochromatin is well known, yet the specific mechanisms underlying this link remain uncertain. In Saccharomyces cerevisiae, the histone deacetylase Sir2 is required for both transcriptional silencing and late replication at the repetitive ribosomal DNA (rDNA) arrays. We have previously reported that in the absence of SIR2, a de-repressed RNA PolII repositions MCM replicative helicases from their loading site at the ribosomal origin, where they abut well-positioned, high-occupancy nucleosomes, to an adjacent region with lower nucleosome occupancy. By developing a method that can distinguish activation of closely spaced MCM complexes, here we show that the displaced MCMs at rDNA origins have increased firing propensity compared to the nondisplaced MCMs. Furthermore, we found that both activation of the repositioned MCMs and low occupancy of the adjacent nucleosomes critically depend on the chromatin remodeling activity of FUN30. Our study elucidates the mechanism by which Sir2 delays replication timing, and it demonstrates, for the first time, that activation of a specific replication origin in vivo relies on the nucleosome context shaped by a single chromatin remodeler.

    1. Chromosomes and Gene Expression
    2. Structural Biology and Molecular Biophysics
    Liza Dahal, Thomas GW Graham ... Xavier Darzacq
    Research Article

    Type II nuclear receptors (T2NRs) require heterodimerization with a common partner, the retinoid X receptor (RXR), to bind cognate DNA recognition sites in chromatin. Based on previous biochemical and overexpression studies, binding of T2NRs to chromatin is proposed to be regulated by competition for a limiting pool of the core RXR subunit. However, this mechanism has not yet been tested for endogenous proteins in live cells. Using single-molecule tracking (SMT) and proximity-assisted photoactivation (PAPA), we monitored interactions between endogenously tagged RXR and retinoic acid receptor (RAR) in live cells. Unexpectedly, we find that higher expression of RAR, but not RXR, increases heterodimerization and chromatin binding in U2OS cells. This surprising finding indicates the limiting factor is not RXR but likely its cadre of obligate dimer binding partners. SMT and PAPA thus provide a direct way to probe which components are functionally limiting within a complex TF interaction network providing new insights into mechanisms of gene regulation in vivo with implications for drug development targeting nuclear receptors.